TARS Latest Press Releases

-- November 5, 2026 --

Tarsus to Participate in Upcoming Investor Conferences Globe Newswire 4:30 PM

-- November 3, 2026 --

Tarsus Reports Third Quarter 2026 Financial Results Globe Newswire 4:05 PM

-- October 29, 2026 --

Tarsus to Report Third Quarter 2026 Financial Results on Tuesday, November 3, 2026 Globe Newswire 4:30 PM

-- October 28, 2026 --

Tarsus Pharmaceuticals Appoints Neera Clase as Chief Commercial Officer Globe Newswire 8:30 AM

-- October 14, 2026 --

Lisata Therapeutics Appoints Jeff Farrow to Board of Directors Globe Newswire 4:05 PM

-- September 29, 2026 --

Tarsus Plans to Present 11 Abstracts Highlighting New Insights in Demodex Blepharitis, Ocular Rosacea and the Real-World Impact of XDEMVY at the American Academy of Optometry 2026 Annual Meeting Globe Newswire 8:30 AM

-- September 4, 2026 --

Tarsus Pharmaceuticals Completes Acquisition of Alkeus Pharmaceuticals, Expanding Leadership in Eye Care Globe Newswire 8:38 AM

-- September 3, 2026 --

Alkeus Announces Publication in JAMA Ophthalmology of Efficacy and Safety Results from the TEASE-1 Study of Gildeuretinol in Stargardt Disease Globe Newswire 11:10 AM

-- September 1, 2026 --

Tarsus to Participate in Upcoming Investor Conferences Globe Newswire 4:30 PM

-- August 24, 2026 --

Alkeus Pharmaceuticals Announces Japan Ministry of Health, Labour and Welfare (MHLW) Has Granted Orphan Drug Designation to Gildeuretinol for Stargardt Disease Globe Newswire 8:30 AM

-- August 6, 2026 --

Tarsus Reports Second Quarter 2026 Financial Results, Advances Next Phase of Growth Globe Newswire 7:03 AM

Tarsus Pharmaceuticals Announces Oversubscribed $125.0 Million Private Placement Equity Financing Globe Newswire 7:02 AM

Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals and Advance Eye Care Leadership Position Globe Newswire 7:01 AM

-- August 5, 2026 --

Tarsus to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026 Globe Newswire 8:02 PM

-- July 13, 2026 --

Tarsus Pharmaceuticals Announces Executive Leadership Transition as Company Advances Next Phase of Growth Globe Newswire 4:05 PM

-- July 8, 2026 --

Tarsus Advances Eye Care Leadership Strategy with Acquisition of iRenix Medical and Late-Stage Asset IRX-101 Globe Newswire 4:05 PM

Market Data Delayed 15 Minutes